[HTML][HTML] Current approaches in the treatment of relapsed and refractory acute myeloid leukemia
NR Ramos, CC Mo, JE Karp, CS Hourigan - Journal of clinical medicine, 2015 - mdpi.com
The limited sensitivity of the historical treatment response criteria for acute myeloid leukemia
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia.
NR Ramos, CC Mo, JE Karp… - Journal of Clinical …, 2015 - europepmc.org
The limited sensitivity of the historical treatment response criteria for acute myeloid leukemia
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
[PDF][PDF] Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
NR Ramos, CC Mo, JE Karp, CS Hourigan - AML in the Molecular Age, 2015 - mdpi.com
The limited sensitivity of the historical treatment response criteria for acute myeloid leukemia
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
NR Ramos, CC Mo, JE Karp… - Journal of clinical …, 2015 - pubmed.ncbi.nlm.nih.gov
The limited sensitivity of the historical treatment response criteria for acute myeloid leukemia
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
Current approaches in the treatment of relapsed and refractory acute myeloid leukemia
NR Ramos, CC Mo, JE Karp - Journal of Clinical Medicine, 2015 - pure.johnshopkins.edu
The limited sensitivity of the historical treatment response criteria for acute myeloid leukemia
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
[PDF][PDF] Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
NR Ramos, CC Mo, JE Karp, CS Hourigan - J. Clin. Med, 2015 - pdfs.semanticscholar.org
The limited sensitivity of the historical treatment response criteria for acute myeloid leukemia
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
[PDF][PDF] Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
NR Ramos, CC Mo, JE Karp, CS Hourigan - J. Clin. Med, 2015 - academia.edu
The limited sensitivity of the historical treatment response criteria for acute myeloid leukemia
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
[HTML][HTML] Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
NR Ramos, CC Mo, JE Karp… - Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
The limited sensitivity of the historical treatment response criteria for acute myeloid leukemia
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
[PDF][PDF] Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
NR Ramos, CC Mo, JE Karp… - J Clin Med. Author …, 2015 - researchgate.net
The limited sensitivity of the historical treatment response criteria for acute myeloid leukemia
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
[PDF][PDF] Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
NR Ramos, CC Mo, JE Karp… - AML in the Molecular …, 2015 - scholar.archive.org
The limited sensitivity of the historical treatment response criteria for acute myeloid leukemia
(AML) has resulted in a different paradigm for treatment compared with most other cancers …
(AML) has resulted in a different paradigm for treatment compared with most other cancers …